Trial
NCT02644525
Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Loiasis
Intervention
Imatinib Mesylate
Why stopped
Planned interim analysis demonstrated futility of intervention
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-07